Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of inhaled magnesium sulfate plus standard treatment in Covid-19 patients
IRCT20191211045691N1Phase 3Completed
- Sponsor
- Masih Daneshvari Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in coronavirus disease 2019 (COVID-19), sponsored by Masih Daneshvari Hospital. Started Jul 2020; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20191211045691N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191211045691N1.